Clinical Trial Update: Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine [Phase 2]

View source ↗

Summary

Phase II trial update evaluating safety and immunogenicity of an attenuated dengue vaccine (Dengue 1,2,3,4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Dengue 1,2,3,4 (Attenuated) Vaccine

Snippet

Sponsor: Butantan Institute | Conditions: Dengue | Phase 2 | Status: UNKNOWN